Conclusion: GLP-1s are highly effective for managing blood sugar and promoting weight loss, with added cardiovascular and other health benefits including decreasing rate/risk of 14 obesity related cancers (colon, endometrial, etc) as per MD Anderson
At this point there is quite a bit of data about glutathione and ASD to the point where glutathione levels and enzymes involved in glutathione production could actually predict ASD.It makes a lot of sense, actually, given what we know about oxidative damage in the brain
NEW YORK August 4, 2025 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Follow Up: Advise patients on any potential side effects and provide post-injection care instructions